摘要
葡萄糖与含氨基生物分子(主要为蛋白质,也包括核酸和脂类)可发生复杂的反应,最后形成一类结构复杂的化合物,称为糖化终末产物fadvancedglycationendproducts,AGEs)。AGEs结构极为复杂,与很多病理生理过程密切相关。
出处
《内科理论与实践》
2012年第3期152-155,共4页
Journal of Internal Medicine Concepts & Practice
参考文献18
-
1王瑞良,苏青.RAGE及其配体的临床意义研究进展[J].国际内分泌代谢杂志,2006,26(3):160-162. 被引量:23
-
2Giacco F, Brownlee M. Oxidative stress and diabetic complications[J]. Circ Res, 2010, 107(9): 1058-1070.
-
3葛勤敏,边帆,许勤,苏青.糖化终末产物对内皮细胞氧化应激的影响[J].上海交通大学学报(医学版),2007,27(2):178-181. 被引量:6
-
4Ge QM, Dong Y, Su Q. Effects of glucose and advanced glycation end products on oxidative stress in MIN6 cells [J]. Cell Mol Biol (Noisy-le-grand), 2010, 56 Suppl: OL1231-OL1238.
-
5杜世春,林宁,葛勤敏,简蔚霞,董艳,苏青.糖化终末产物对MIN6细胞活力及活性氧(ROS)水平的影响[J].中华内分泌代谢杂志,2011,27(2):152-154. 被引量:5
-
6Lin N, Zhang H, Su Q. Advanced glycation end-products induce injury to pancreatic 15 cells through oxidative stress[J]. Diabetes Metab, 2012. [Epub ahead of print].
-
7Reiniger N, Lau K, McCalla D, et al. Deletion of the receptor for advanced glycation end products reduces glo- merulosclerosis and preserves renal function in the dia-betic OVE26 mouse[J]. Diabetes, 2010, 59(8): 2043-2054.
-
8Sheikpranbabu S, Haribalaganesh R, Gurunathan S. Pigment epithelium-derived factor inhibits advanced glyeation end-products-induced cytotoxicity in retinal pericytes[J]. Diabetes Metab, 2011, 37(6): 505-511.
-
9Sheikpranbabu S, Haribalaganesh R, Banumathi E, et al. Pigment epithelium-derived factor inhibits advanced gly- cation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells [J]. Life Sci, 2009, 85(21-22): 719-731.
-
10Ide Y, Matsui T, Ishibashi Y, et al. Pigment epithelium- derived factor inhibits advanced glycation end product- elicited mesangial cell damage by blocking NF-KB acti- vation[J]. Microvasc Res, 2010, 80(2): 227-232.
二级参考文献31
-
1Yamagishi S.Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.Ther Apher Dial,2009,13,6:534-539.
-
2Yan SF,Barile GR,D' Agati V,et al.The biology of RAGE and its ligands:uncovering mechanisms at the heart of diabetes and its complications.Curr Diab Rep,2007,7:146-153.
-
3Yan SF,Yan SD,Herold K,et al.Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond:lessons from ageing.Endocrinol Metab Clin North Am,2006,35:511-524.
-
4Lim M,Park L,Shin G,et al.Induction of apoptosis of β cells of the pancreas by advanced glycation end-products,important mediators of chronic complications of diabetes mellitus.Ann N Y Acad Sci,2008,1150:311-315.
-
5Luciano Viviani G,Puddu A,Sacchi G,et al.Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro.Metabolism,2008,57:163-169.
-
6Fenster BE,Tsao PS,Rockson SG.Endothelial dysfunction:clinical strategies for treating oxidant stress.Am Heart J,2003,146,2:218-226.
-
7Schmitt A,Bigl K,Meiners I,et al.Induction of reactive oxygen species and cell survival in the presence of advanced glycation end products and similar structures.Biochim Biophys Acta,2006,1763,9:927-936.
-
8Forbes JM, Thallas V, Thomas MC, et al. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J, 2003,17 : 1762-1764.
-
9Candido R, Forbes JM, Thomas MC, et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes: Circ Res, 2003,92:785-792.
-
10Haslbeck KM, Schleieher E, Bierhaus A, et al. The AGEVRAGE/NF-kappaB pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT). Exp Clin Endocrinol Diabetes,2005,113 : 288-291.
共引文献28
-
1Xiaoqin Du,Xin Fu,Quan Hao.Expression and Clinical Significance of HMGB1 and RAGE in Cervical Carcinoma[J].Chinese Journal of Clinical Oncology,2007,4(5):343-346. 被引量:1
-
2张磊,李牧,祁磊,蔡中续,李玉华,孙元亮.晚期糖基化终末产物在糖尿病大鼠骨质疏松发病中的作用及胰岛素潜在的防护机制[J].山东大学学报(医学版),2007,45(11):1148-1152. 被引量:4
-
3李晓永,张洪梅,董艳,葛勤敏,陈寒蓓,刘继红,代伶俐,周亚琴,苏青.糖化终末产物受体在大鼠胰腺星形细胞中的表达[J].新乡医学院学报,2008,25(2):137-140. 被引量:4
-
4王瑞良,张洪梅,董艳,苏青.依帕司他对糖尿病大鼠肾组织糖化终末产物受体表达的影响[J].上海医学,2008,31(11):778-780. 被引量:2
-
5牛丽丽,许玉韵.糖基化终末产物与急性冠状动脉综合征[J].中华老年心脑血管病杂志,2009,11(2):150-152. 被引量:3
-
6许洪燕,方敬爱,孙艳艳,张晓东,刘文媛,王蕊花,常沁涛,范彦君.RAGE及sRAGE与糖尿病肾病关系的研究进展[J].中国中西医结合肾病杂志,2009,10(5):465-467. 被引量:1
-
7桑瑜,成兴波.2型糖尿病患者血浆钙结合蛋白复合物与颈动脉粥样硬化的相关性[J].江苏医药,2010,36(9):1003-1005. 被引量:6
-
8丛潇,王友政,张文生.晚期糖基化终末产物受体与阿尔茨海默病[J].中国老年学杂志,2010,30(12):1759-1761. 被引量:11
-
9郁海燕,张利华,冯斌,韩伟,任引刚.稳定型心绞痛患者血清sRAGE水平与冠脉病变复杂程度的相关性[J].山西医科大学学报,2011,42(4):307-310. 被引量:3
-
10周小智,薛耀明,关美萍,朱波.晚期糖基化终产物对人结肠癌细胞SW-480增殖的影响及其机制研究[J].华西医学,2011,26(6):837-841.
同被引文献36
-
1Evan J.Raff,Donny Kakati,Joseph R.Bloomer,Mohamed Shoreibah,Khalid Rasheed,Ashwani K.Singal.Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases[J].Journal of Clinical and Translational Hepatology,2015,3(1):9-16. 被引量:34
-
2崔亮,孙宜萍.糖基化终末产物在血管病变中的作用[J].上海医学,2002,25(z1):129-130. 被引量:4
-
3Masayoshi Takeuchi,Jun-ichi Takino,Akiko Sakasai-Sakai,Takanobu Takata,Tadashi Ueda,Mikihiro Tsutsumi,Hideyuki Hyogo,Sho-ichi Yamagishi.Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies[J].World Journal of Hepatology,2014,6(12):880-893. 被引量:5
-
4王瑞良,苏青.RAGE及其配体的临床意义研究进展[J].国际内分泌代谢杂志,2006,26(3):160-162. 被引量:23
-
5葛勤敏,边帆,许勤,苏青.糖化终末产物对内皮细胞氧化应激的影响[J].上海交通大学学报(医学版),2007,27(2):178-181. 被引量:6
-
6SATO T, IWAKI M, SHIMOGAITO N, et al. TAGE (toxic AGEs) theory in diabetic complications[J]. Curr Mol Med, 2006, 6(3): 351-358.
-
7TAKEUCHI M, TAKINO J, YAMAGISHI S. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications., a novel therapeutic strategy[J]. Curr Drug Targets, 2010, 11(11) :1468-1482.
-
8TAKEUCHI M, YANASE Y, MATSUURA N, et al. Immunological detection of a novel advanced glycation end- product[J]. MolMed, 2001, 7(11): 783-791.
-
9GE Q M, DONG Y, SU Q. Effects of glucose and advanced glycation end products on oxidative stress in MIN6 cells[J]. Cell Mol Biol (Noisy-le-grand), 2010, 56(Suppl) : OL1231- 0L1238.
-
10LIN N, ZHANG H, SU Q. Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress[J].Diabetes Metab, 2012, 38(3): 250-257.
引证文献4
-
1张月成,林宁,秦利,苏青.不同来源糖化终末产物对胰岛素细胞氧化应激的影响[J].上海医学,2013,36(5):442-445. 被引量:1
-
2李亚葵,陈寒蓓,童雪梅,苏青.糖化终末产物对人结肠癌HCT116细胞氧化应激的影响[J].上海交通大学学报(医学版),2014,34(9):1350-1354. 被引量:1
-
3苏青.糖代谢异常人群筛查非酒精性脂肪性肝病的重要性[J].诊断学理论与实践,2016,15(4):342-345. 被引量:2
-
4陈寒蓓,林宁,苏青.糖化终末产物对人结肠癌HCT116细胞中ChREBP表达的影响[J].同济大学学报(医学版),2018,39(3):30-35. 被引量:1
二级引证文献5
-
1林宁,李晓永,张洪梅,苏青.糖化终末产物刺激胰岛中NADPH氧化酶水平升高[J].实用医学杂志,2014,30(6):875-878. 被引量:3
-
2朱明辉,陈蕾.肝硬化患者糖脂代谢水平及其对疾病恶化的影响[J].中国中西医结合消化杂志,2017,25(8):621-624. 被引量:4
-
3陈寒蓓,林宁,苏青.糖化终末产物对人结肠癌HCT116细胞中ChREBP表达的影响[J].同济大学学报(医学版),2018,39(3):30-35. 被引量:1
-
4张俊华,薛敏,肖松舒,易水晶,曾飞.Mondo蛋白在肿瘤相关代谢中的研究进展[J].生命的化学,2019,39(1):88-95.
-
5冯清波,周昕,王麦建,郑兴斌,李正彪,胡旭,谢铭.基于Web of Science数据库中减重代谢手术研究的可视化及热点分析[J].中华消化外科杂志,2024,23(8):1112-1122.
-
1马春华.冠心病合并糖耐量异常的临床研究[J].辽东学院学报(自然科学版),2011,18(4):281-286. 被引量:5
-
2超楚生.糖尿病与冠心病[J].糖尿病新世界,2001,0(5):3-3.
-
3苏苹,何宇梅,王晓焕.糖尿病患者高糖化终末产物饮食应激对内皮功能的影响[J].临床荟萃,2008,23(15):1086-1087.
-
4郑凝,张宏,曾淑范.糖尿病肾病患者血清低分子糖化终末产物的测定[J].中国慢性病预防与控制,2005,13(6):289-291. 被引量:3
-
5葛勤敏,边帆,许勤,苏青.糖化终末产物对内皮细胞氧化应激的影响[J].上海交通大学学报(医学版),2007,27(2):178-181. 被引量:6
-
6苏青.专家专题报告8:AGEs对胰岛β细胞的影响[J].中华内分泌代谢杂志,2014,30(3):272-273. 被引量:1
-
7侯芳玉,徐效义,施雨露.糖化终末产物对大肠杆菌增殖与粘附的影响[J].微生物学杂志,2001,21(4):52-53.
-
8何宇梅,赵松,刘婷.糖尿病与非糖尿病之间的AGE激化对内皮功能的比较[J].中国老年保健医学,2013,11(2):19-20.
-
9王忠波,马晓菊,张颖.超声对2型糖尿病患者颈动脉粥样硬化的检测分析[J].临床超声医学杂志,2012,14(3):213-214. 被引量:1
-
10陈惠,田密,韩彩和,张京,乌晴.AGEs与葡萄糖浓度对血管内皮细胞增生的影响[J].首都医科大学学报,2003,24(2):133-134. 被引量:2